Matrix Tablets: An Effective Way for Oral Controlled Release Drug Delivery Controlled drug delivery using matrix tablets
Iranian Journal of Pharmaceutical Sciences,
Vol. 8 Núm. 3 (2012),
1 July 2012
,
Página 165-170
https://doi.org/10.22037/ijps.v8.40934
Resumen
The purpose of this review article is to characterize all of the parameters regarding the types, polymers used, and release kinetics of matrix tablets. Matrix system was the earliest oral extended release platform for medicinal use. Matrix tablets are most commonly used methods to modulate the release profile of drugs. They are much desirable and preferred for such therapy because they offer better patient compliance, maintain uniform drug levels, reduce dose and side effects, and increase safety margin for high potency drugs. Hydrophilic polymer matrix systems are widely used for designing oral controlled drug delivery dosage forms because of their flexibility to provide a desirable drug release profile, cost effectiveness, and broad regulatory acceptance. However, the use of hydrophilic matrix alone for extending drug release for highly water soluble drugs is restricted due to rapid diffusion of the dissolved drug through the hydrophilic gel network. For such drugs it becomes essential to include hydrophobic polymers in the matrix system. This leads to the conclusion that matrix tablets seem to be most promising when developing an oral controlled release formulation.
- Controlled release
- Hydrophilic matrix
- Hydrophobic matrix
- Matrix
Cómo citar
Citas
[2] Brahmankar HA, Jaiswal SB. Biopharmaceutics and pharmacokinetics. A Treatise, Vallabh Prakashan, 2000; pp. 337, 348-357.
[3] Ratner BD, Kwok C. Characterization of delivery system, surface analysis and controlled release system. In: Encyclopaedia of controlled drug delivery, Vol-I. John Wiley & Sons, USA; 1999; pp. 349-62.
[4] Nishihata T, Tahara K, Yamamoto K. Overall mechanisms behind matrix sustained release tablets prepared with hydroxypropyl cellulose 2910. J Controlled Release 1995; 35: 59-66.
[5] Pina ME, Salsa T, Veiga F. Oral controlled release dosage forms. I. cellulose ether polymers in hydrophilic matrices. Drug Dev Ind Pharm 1997; 23: 929-38.
[6] Martini L, Close M, Gravell K. Use of a hydrophobic matrix for the sustained release of a highly water soluble drug. Drug Dev Ind Pharm 2000; 26: 79-83.
[7] Qiu Y, Zhang G, Wise DL. Release and development aspects of oral controlled-release dosage forms. Handbook of pharmaceutical controlled release technology. New York, Marcel Dekker, Inc., 2000, pp.465-503.
[8] Borguist P, Korner A, Larsson A. A model for the drug release from a polymeric matrix tabletseffect of swelling and dissolution. J Controlled Release 2006; 113: 216-25.
[9] Munday DC, Cox PJ. Compressed xanthan and karaya gum matrices: hydration, erosion and drug release mechanism. Int J Pharm2000; 203: 179-92.
- Resumen ##plugins.themes.ojsPlusA.frontend.article.viewed##: 152 ##plugins.themes.ojsPlusA.frontend.article.times##
- IJPS_Volume 8_Issue 3_Pages 165-170 (English) ##plugins.themes.ojsPlusA.frontend.article.downloaded##: 38 ##plugins.themes.ojsPlusA.frontend.article.times##